Agilon Health Inc. (AGL)
NYSE
93.79
-2.79 (-2.89%)
Real-time Data
01:30 PM
Day's Range
91.7897.64
52 wk Range
7.48133.04
Financial Statements - AGL - Agilon Health Inc.
Revenue
5.93B▼ 2.1%
Net Income
-391.34M▼ 50.5%Net Margin -6.6%
EBITDA
-332.77M▼ 55.1%
Free Cash Flow
-148.87M▼ 50.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 5.93B | 6.06B | 4.31B | 2.38B | 1.52B | 1.21B |
| Cost of Goods | 6.09B | 6.05B | 4.24B | 2.27B | 1.45B | 1.12B |
| Gross Profit | -160.02M | 4.84M | 69.67M | 111.36M | 65.74M | 94.15M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -427.15M | -288.53M | -232.13M | -105.37M | -372.24M | -56.67M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 29.69M | 45.88M | 44.32M | 19.19M | -4.58M | 2.46M |
| Pre Tax Income | -404.09M | -248.82M | -194.46M | -90.67M | -382.97M | -62.34M |
| Income Tax | 1.25M | 1.45M | 791K | 1.64M | 886K | 865K |
| Net Income | -391.34M | -260.10M | -262.80M | -106.86M | -406.78M | -60.05M |
| EPS Basic | -23.75 | -0.63 | -0.64 | -0.26 | -1.09 | -0.156046 |
| EPS Diluted | -23.75 | -0.63 | -0.64 | -0.26 | -1.09 | -0.156046 |
| Basic Shares Outstanding | 16.55M | 410.96M | 408.91M | 408.15M | 372.93M | 384.83M |
| Diluted Shares Outstanding | 16.55M | 410.96M | 408.91M | 408.15M | 372.93M | 384.83M |
| Ebit | -397.45M | -242.64M | -187.80M | -86.18M | -376.83M | -54.20M |
| Ebitda | -332.77M | -214.59M | -167.64M | -66.95M | -362.16M | -40.10M |
| Net Income Continuous Operations | -391.34M | -260.10M | -262.80M | -106.86M | -406.78M | -60.05M |
| Minority Interests | 0 | -50K | 207K | 311K | 300K | 0 |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
